in a multi-center , double-blind , placebo-controlled trial in claudicating patients with peripheral atherosclerosis , the effects of 1 year of treatment with ketanserin ( 20 mg t.i.d . for 1 month , 40 mg t.i.d . thereafter ; n = 63 patients ) or placebo ( n = 84 patients ) on platelet function ( aggregation in p.r.p . by 5-ht 5 x 10 ( -6 ) m , adp 1 to 5 x 10 ( -6 ) m , collagen 2 micrograms/ml ; platelet 5-ht content ; plasma beta tg- and pf4-levels ; serum txb2 ) were analyzed .
C0032105
plasma
C0229671
serum